Search Results - "Saadeh, F. Abu"

Pelvic actinomycosis by Floyd, R, Hunter, S, Abu Saadeh, F, McDonnell, C, McCormick, P

Get full text

Extended thromboprophylaxis post gynaecological cancer surgery; the effect of weight adjusted and fixed dose LMWH (Tinzaparin) by Abu Saadeh, F., Marchocki, Z., O'Toole, S.A., Ibrahim, N., Gleeson, N., Norris, L.A.

“…Gynaecological cancer surgery is associated with high rates of venous thromboembolism (VTE) despite recommended prophylaxis. We sought to investigate the…”
Get full text

P-077: Risk of recurrence of venous thromboembolism in patients with gynaecological cancer by Marchocki, Z, Abu Saadeh, F, Gleeson, N, Norris, L

Get full text

Procoagulant activity in gynaecological cancer patients; the effect of surgery and chemotherapy by Abu Saadeh, F, Langhe, R, Galvin, D.M, O Toole, S.A, O'Donnell, D.M, Gleeson, N, Norris, L.A

“…Abstract Background Gynaecological cancers are associated with high rates of venous thromboembolism (VTE). Studies on ambulatory cancer patients do not support…”
Get full text

OC-12 - Peri operative venous thromboembolism prophylaxis in gynaecological cancer patients. A survey of current practice by Petch, S, Norris, L.A, O’Toole, S.A, Gleeson, N, Saadeh, F. Abu

“…Introduction Gynaecological cancer is associated with some of the highest rates of venous thromboembolism (VTE) with some subtypes of ovarian cancer associated…”
Get full text

PO-24 - Determinants of thrombin generation in gynaecological malignancies by Norris, L.A, Martin, F.A, O’Toole, S.A, Saadeh, F. Abu, Gleeson, N

“…Introduction Increased thrombin production is associated with malignancy and is a marker for venous thromboembolism (VTE). Our group has shown that thrombin…”
Get full text

PO-14 - Tumour expression of coagulation proteases of the aPC pathway – a role in the pathogenesis of gynaecological cancers? by Martin, F, Long, J.C, O’Toole, S.A, O’Leary, J.J, Abu Saadeh, F, Gleeson, N, Norris, L.A

“…Introduction The close relationship between coagulation, thrombosis and cancer has long been established. Gynaecological cancers, in particular ovarian…”
Get full text

P.86 The role of tissue factor and tissue factor pathway inhibitor in ovarian cancer by Abu Saadeh, F, Norris, L, O'Toole, S, Gleeson, N

Get full text

PO-06: Thrombomodulin as a marker for VTE following neoadjuvant chemotherapy by Ward, M.P., Ibrahim, E., O’Toole, S., Gleeson, N., Abu Saadeh, F., O’Donnell, D., Norris, L.A.

Get full text

PO-03 Is extended thromboprophylaxis required for all gynaecological cancer patients post-surgery? by Abu Saadeh, F., Marchocki, Z., O’Toole, S.A., Gleeson, N., Kashan, A., Norris, L.A.

Get full text

Patients experience and compliance with extended LMWH prophylaxis post-surgery for gynaecological cancer by Marchocki, Z., Norris, L.N., O’Toole, S.A., Gleeson, N., Abu Saadeh, F.

Get full text

Development and validation of a risk model for prediction of venous thromboembolism in gynaecological cancer patients by Norris, L.A., Abu Saadeh, F., Ward, M., O'Toole, S.A., Machocki, Z., Ibrahim, N., Gleeson, N.

Get full text

Fibrinogen, D-Dimers and thrombin generation assays as predictors of the risk of recurrent VTE in patients with gynaecological malignancies by Marchocki, Z., Gleeson, N., Abu Saadeh, F., Ward, M.P., O’Toole, S.A., Norris, L.A.

Get full text

TEMPORARY REMOVAL: PO-06: Thrombomodulin as a marker for VTE following neoadjuvant chemotherapy by Ward, M P, Ibrahim, E, O'Toole, S, Gleeson, N, Abu Saadeh, F, O'Donnell, D, Norris, L A

“…The publisher regrets that this article has been temporarily removed. A replacement will appear as soon as possible in which the reason for the removal of the…”
Get full text

Contemporary Management of Locally Advanced and Recurrent Rectal Cancer: Views from the PelvEx Collaborative by PelvEx Collaborative, PelvEx Collaborative

“…Pelvic exenteration is a complex operation performed for locally advanced and recurrent pelvic cancers. The goal of surgery is to achieve clear margins,…”
Get full text

PO-22 Does tissue factor and tissue factor pathway inhibitor over expression, play a role in the development of venous thromboembolism in ovarian cancer patients? by Saadeh, F. Abu, Norris, L., O'Toole, S., Langhe, R., O'Leary, J.J., Gleeson, N.

Get full text

PO-76 Procoagulant activity in patients with gynaecological malignancies and the effect of neoadjuvant chemotherapy by Saadeh, F. Abu, Norris, L., O'Toole, S., Langhe, R., Gleeson, N.

Get full text

Procoagulant activity in patients with gynaecological malignancies and the effect of neoadjuvant chemotherapy by Saadeh, F. Abu, Norris, L, O'Toole, S, Langhe, R, Gleeson, N

Get full text

Does tissue factor and tissue factor pathway inhibitor over expression, play a role in the development of venous thromboembolism in ovarian cancer patients? by Saadeh, F. Abu, Norris, L, O'Toole, S, Langhe, R, O'Leary, J.J, Gleeson, N

Get full text